Comparing classic pulmonary rehabilitation with a singing-based training, a Danish study found non-inferiority of the singing method to improve physical capacity in COPD patients [1].
“As you all know, pulmonary rehabilitation is a cornerstone in COPD care and has an immense impact on subjective and objective aspects of living with COPD,” said Prof. Uffe Bødtger (Nætved Hospital, Denmark). Unfortunately, adherence to pulmonary rehabilitation can be quite a problem, which is why there is a need for alternative options [2,3].
“Within the last 20 years or so, lung choirs or singing training for patients with respiratory diseases including COPD has shown to improve respiratory control, dyspnoea levels, and self-perceived physical health, but the impact on physical capacity is unknown,” Prof. Bødtger explained the motivation for this multicentre, randomised-controlled trial [1]. As such, the primary endpoint of this investigation comparing singing training with physical training was non-inferiority in improvement of physical capacity demonstrated by change in 6-minute walking test (6MWT). Secondary endpoints included quality of life, lung function (FEV1), overall disease-specific health (St. George's Respiratory Questionnaire, SGRQ), and adherence.
The study randomised 270 patients who had a prescription for pulmonary rehabilitation from August 2017 to August 2019, of whom 195 completed their rehabilitation over 10 weeks. Baseline parameters between groups were comparable. The patients had a mean age of 69 years and a mean FEV1 of 51%. About two-thirds were female and around 73% were on double or triple inhalation treatment.
The result showed no difference in the magnitude of difference in the 6MWT between singing training and standard physical training (P=0.81). However, in some of the secondary endpoints, patients with singing training demonstrated more significant disparities in the within-group changes: e.g. SGRQ (singing training group vs physical training group: P<0.001 vs P=0.08), predicted FEV1 (P=0.04 vs P=0.35). Nevertheless, no differences in training adherence, nor in dyspnoea, anxiety, and depression were observed between the different rehabilitation regimens. Adverse events were not reported.
“In conclusion, it appears that singing training could be as effective as physical training in improving physical capacity in COPD patients attending rehabilitation. However, there is a long way in exploring and standardising the optimal content of singing training,” said Prof. Bødtger.
- Kaasgaard M, et al. Sing-a-Lung: Group singing as training modality in pulmonary rehabilitation for patients with Chronic Obstructive Pulmonary Disease (COPD): A multicenter, cluster-randomised, non-inferiority controlled trial. Abstract 4663, ERS International Virtual Congress 2020, 7-9 Sept.
- Jones SE, et al. Thorax. 2014;69(2):181-182.
- Hayton C, et al. Respir Med. 2013;107:401-407.
Posted on
Previous Article
« Mild asthma: A fundamental change in management Next Article
Exacerbation history is a reliable predictor of future exacerbations »
« Mild asthma: A fundamental change in management Next Article
Exacerbation history is a reliable predictor of future exacerbations »
Table of Contents: ERS 2020
Featured articles
COVID-19 and the Lung
COVID-19 infections: Bronchoscopy provides additional diagnostic certainty
COVID-19 vaccines: An ongoing race
COVID-19: What is the risk of reinfection?
COVID-19 App: The Dutch experience
Secondary pulmonary fibrosis: a possible long-term effect of severe COVID-19
COVID-19 survivors benefit from structured follow-up
Early pulmonary rehabilitation post-COVID-19 aids recovery
Asthma – What's New
Mild asthma: A fundamental change in management
Dupilumab shows long-term efficacy in asthma patients
Severe asthma: Oral corticosteroids maintenance therapy associated with toxicity
First-in-class tyrosine kinase inhibitor shows promise in severe asthma
Predicting individual effectiveness of biologics in severe asthma
IL-5 antagonist showed efficacy in chronic rhinosinusitis with nasal polyps
Treatment according to genotype: The future of asthma therapy?
COPD – The Beat Goes On
The role of chronic symptoms as early biomarkers of COPD development
Urgent call for studies in COPD patients aged 40-60 years
Nasal high-flow therapy: a novel treatment option for hypercapnic COPD patients
Exacerbation history is a reliable predictor of future exacerbations
Singing training effective as physical rehabilitation in COPD
Current prediction tools underestimate exacerbation risk of severe COPD patients
Exercise and Sleep: From Impaired Function to New Therapeutic Strategies
CPAP withdrawal has negative consequences for sleep apnoea patients
Physical activity improves AHI in sleep apnoea patients
The Tobacco Epidemic: From Vaping to Cannabis
Poly-use of nicotine products and cannabis: a deadly combination
E-cigarettes: A source of chronic lung inflammation
Social smoking: Do not underestimate the risks
Chronic Cough – State of the Art
LEAD study shows multiple phenotypes in many chronic cough patients
First-in-class P2X3 receptor antagonist shows promise for chronic cough treatment
Lung Cancer Detection
Lung cancer screening: Most patients not eligible 1-2 years prior to diagnosis
Distinct changes in lung microbiome precede clinical diagnosis of lung cancer
Best of Posters
Smartphone-based cough detection helpful in predicting asthma deterioration
Reduced lung function associated with cognitive decline in the elderly
Longer hospital stay and fewer transplants for frail ILD patients
Related Articles
September 22, 2022
ERS 2022 Highlights Podcast
July 18, 2022
New guidelines for IPF and PPF
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com